Recent research has unveiled intriguing connections between genetic factors and the effectiveness of weight-loss drugs such as Wegovy and Mounjaro, offering valuable insights into why responses to these treatments can vary significantly among individuals. The study, published in the esteemed journal Nature, highlights the role of specific genetic variations associated with appetite regulation and digestion, which may result in varying degrees of weight loss and side effects among users.
Genetic Variations and Weight Loss
The investigation, which analysed data from 15,000 individuals who participated in gene-testing through the platform 23andMe, provides compelling evidence that certain genetic variants can influence weight loss outcomes when using these medications. Participants reported an average weight loss of 11.7% over approximately eight months, with some individuals shedding as much as 30% of their body weight. The findings suggest that those carrying specific genetic traits have the potential to lose more weight—around 0.76 kg (1.6 lbs) on average—compared to those without these variants.
Professor Ruth Loos from the University of Copenhagen, one of the study’s authors, noted, “The study found a genetic variant associated with weight loss, which was also associated with nausea. People lose more weight if they have this variant.” The research indicates that while 64% of individuals with European ancestry carry at least one copy of this variant, only 7% of African Americans do, underscoring the role of ancestry in genetic predisposition to weight loss with these medications.
Side Effects and Their Genetic Underpinnings
Additionally, the study identified another genetic variant that may exacerbate side effects, particularly nausea and vomiting, in users of tirzepatide (Mounjaro). This variant could lead to nearly 1% of users experiencing severe vomiting—up to 15 times more intense than the usual side effects. Such findings point towards a genetic basis for the adverse reactions that some individuals face when undergoing treatment, further complicating the landscape of weight management through pharmacological means.
Beyond Genetics: A Multitude of Factors
While genetics play a role, experts emphasise that they are only one piece of a much larger puzzle. Dr Marie Spreckley from the University of Cambridge remarked, “Genetics is only one part of a much more complex picture.” Factors such as behavioural habits, clinical history, and the nature of support received during treatment significantly influence outcomes. Previous studies have indicated that women are over twice as likely as men to achieve a 15% weight loss on Mounjaro, suggesting that sex, age, and ethnicity also contribute to the variability in treatment results.
Moreover, the medication’s type, dosage, and duration of use are critical variables affecting weight loss success. As the landscape of obesity treatment evolves, a more nuanced understanding that incorporates genetic and lifestyle factors could pave the way for precision medicine approaches in prescribing weight-loss drugs.
The Path Forward
Despite these promising insights, experts caution that the findings remain preliminary and require further validation through additional studies. Professor Naveed Sattar, a metabolic health expert from the University of Glasgow, emphasised the need for more robust trial data to fully understand the balance of benefits and risks associated with emerging weight-loss therapies. “Overall, these findings are scientifically interesting, but they are a long way from changing clinical practice,” he stated.
Why it Matters
As obesity rates continue to rise, understanding the interplay between genetics and treatment efficacy is essential for developing personalised weight management strategies. This research not only highlights the potential for targeted therapies based on individual genetic profiles but also underscores the importance of considering a holistic approach that includes behavioural and environmental factors. In a public health context, embracing a multifaceted strategy could enhance the effectiveness of obesity treatments and ultimately lead to better health outcomes for millions struggling with weight-related issues.
